| Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial Z Ghoreishi, A Esfahani, A Djazayeri, M Djalali, B Golestan, H Ayromlou, ... BMC cancer 12, 1-8, 2012 | 177 | 2012 |
| Multiple sclerosis: Therapeutic applications of advancing drug delivery systems S Dolati, Z Babaloo, F Jadidi-Niaragh, H Ayromlou, S Sadreddini, ... Biomedicine & pharmacotherapy 86, 343-353, 2017 | 86 | 2017 |
| Nanocurcumin improves regulatory T-cell frequency and function in patients with multiple sclerosis S Dolati, Z Babaloo, H Ayromlou, M Ahmadi, R Rikhtegar, ... Journal of neuroimmunology 327, 15-21, 2019 | 84 | 2019 |
| Nanocurcumin is a potential novel therapy for multiple sclerosis by influencing inflammatory mediators S Dolati, M Ahmadi, L Aghebti-Maleki, A Nikmaram, F Marofi, R Rikhtegar, ... Pharmacological reports 70 (6), 1158-1167, 2018 | 81 | 2018 |
| Changes in Th17 cells function after nanocurcumin use to treat multiple sclerosis S Dolati, M Ahmadi, R Rikhtegar, Z Babaloo, H Ayromlou, ... International immunopharmacology 61, 74-81, 2018 | 63 | 2018 |
| Guillain-Barré syndrome in a patient infected with SARS-CoV-2, a case report MA Farzi, H Ayromlou, N Jahanbakhsh, PH Bavil, A Janzadeh, FK Shayan Journal of neuroimmunology 346, 577294, 2020 | 56 | 2020 |
| Diagnostic value of ultrasonography and magnetic resonance imaging in ulnar neuropathy at the elbow H Ayromlou, MK Tarzamni, MH Daghighi, MZ Pezeshki, M Yazdchi, ... International Scholarly Research Notices 2012 (1), 491892, 2012 | 56 | 2012 |
| Multiple sclerosis in East-Azerbaijan, north west Iran M Hashemilar, D Savadi Ouskui, M Farhoudi, H Ayromlou, A Asadollahi Neurology Asia 16 (2), 127-31, 2011 | 44 | 2011 |
| Diagnosis and management of neuromyelitis optica spectrum disorder (NMOSD) in Iran: a consensus guideline and recommendations MA Sahraian, AN Moghadasi, AR Azimi, N Asgari, FH Akhoundi, ... Multiple sclerosis and related disorders 18, 144-151, 2017 | 39 | 2017 |
| Genetic association of TNF-α-308 G/A and-863 C/A polymorphisms with late onset Alzheimer's disease in Azeri Turk population of Iran SMM Ardebili, T Yeghaneh, J Gharesouran, M Rezazadeh, M Farhoudi, ... Journal of research in medical sciences: the official journal of Isfahan …, 2011 | 37 | 2011 |
| Changes in plasma concentration of taurine in stroke M Ghandforoush-Sattari, SO Mashayekhi, M Nemati, H Ayromlou Neuroscience letters 496 (3), 172-175, 2011 | 29 | 2011 |
| Oxidative effect of methotrexate administration in spinal cord of rabbits H Ayromlou, B Hajipour, MM Hossenian, A Khodadadi, AM Vatankhah JPMA-Journal of the Pakistan Medical Association 61 (11), 1096, 2011 | 28 | 2011 |
| Effect of vitamin b6 on clinical symptoms and electrodiagnostic results of patients with carpal tunnel syndrome M Talebi, S Andalib, S Bakhti, H Ayromlou, A Aghili, A Talebi Advanced pharmaceutical bulletin 3 (2), 283, 2013 | 27 | 2013 |
| Islamic fasting and multiple sclerosis SR Jahromi, MA Sahraian, F Ashtari, H Ayromlou, M Etemadifar, ... BMC neurology 14, 1-8, 2014 | 25 | 2014 |
| The effects of probiotic Saccharomyces boulardii on the mental health, quality of life, fatigue, pain, and indices of inflammation and oxidative stress in patients with … D Aghamohammadi, H Ayromlou, N Dolatkhah, F Jahanjoo, SK Shakouri Trials 20, 1-9, 2019 | 23 | 2019 |
| The effect of n-3 polyunsaturated fatty acids on incidence and severity of oxaliplatin induced peripheral neuropathy: a randomized controlled trial A Esfahani, MH Somi, H Ayromlou, A Nikanfar, MA Jafarabadi, BE Sadat, ... Biomarker Research 4, 1-9, 2016 | 23 | 2016 |
| Eligibility assessment for intravenous thrombolytic therapy in acute ischemic stroke patients; evaluating barriers for implementation H Ayromlou, H Soleimanpour, M Farhoudi, A Taheraghdam, ... Iranian Red Crescent Medical Journal 16 (5), 2014 | 23 | 2014 |
| Electrodiagnostic evaluation of peripheral nervous system changes in patients with multiple sclerosis H Ayromlou, H Mohammad-Khanli, M Yazdchi-Marandi, R Rikhtegar, ... The Malaysian journal of medical sciences: MJMS 20 (4), 32, 2013 | 22 | 2013 |
| What are the most important barriers for thrombolytic therapy in ischemic stroke patients? H Ayromlou, H Soleimanpour, M Farhoudi, E Sadeghi‐Hokmabadi, ... International Journal of Stroke 8 (4), E7-E7, 2013 | 19 | 2013 |
| Pregnancy outcome in patients with multiple sclerosis treated with Rituximab: a case-series study MS Ahadi, MA Sahraian, SM Baghbanian, A Azimi, V Shaygannejad, ... Multiple Sclerosis and Related Disorders 47, 102667, 2021 | 12 | 2021 |
